BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 3052245)

  • 1. Relationship between Ki-67 positive cells, growth rate and histological type of human intracranial tumors.
    Patsouris E; Stocker U; Kallmeyer V; Keiditsch E; Mehraein P; Stavrou D
    Anticancer Res; 1988; 8(4):537-44. PubMed ID: 3052245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cell kinetics of human meningiomas and neurinomas--Ki-67 PAP stain].
    Shibata T; Burger PC; Kleihues P
    No Shinkei Geka; 1988 Jul; 16(8):939-44. PubMed ID: 3050583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [KI-67 PAP stain for histologic grading of brain tumors by squash preparations].
    Shibata T; Ostertag CB; Volk B
    No To Shinkei; 1989 Jan; 41(1):55-60. PubMed ID: 2470401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of proliferative markers Ki-67 (MIB-1) and proliferating cell nuclear antigen (PC10) in transitional cell carcinoma of the renal pelvis.
    Cheville JC; Terrell RB; Cohen MB
    Mod Pathol; 1994 Sep; 7(7):794-800. PubMed ID: 7824516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative investigation of proliferation markers and their prognostic relevance in human meningiomas.
    Torp SH; Lindboe CF; Granli US; Moen TM; Nordtømme T
    Clin Neuropathol; 2001; 20(5):190-5. PubMed ID: 11594503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and prognostic significance of Ki-67 and proliferating cell nuclear antigen expression in childhood primitive neuroectodermal brain tumors.
    Bodey B; Bodey B; Gröger AM; Siegel SE; Kaiser HE
    Anticancer Res; 1997; 17(1A):189-96. PubMed ID: 9066650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical assessment of proliferative activity in adrenocortical neoplasms.
    Goldblum JR; Shannon R; Kaldjian EP; Thiny M; Davenport R; Thompson N; Lloyd RV
    Mod Pathol; 1993 Nov; 6(6):663-8. PubMed ID: 7508113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value.
    Spyratos F; Ferrero-Poüs M; Trassard M; Hacène K; Phillips E; Tubiana-Hulin M; Le Doussal V
    Cancer; 2002 Apr; 94(8):2151-9. PubMed ID: 12001111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferation indices in spontaneous canine lung cancer: proliferating cell nuclear antigen (PCNA), Ki-67 (MIB1) and mitotic counts.
    Griffey SM; Kraegel SA; Madewell BR
    J Comp Pathol; 1999 May; 120(4):321-32. PubMed ID: 10208729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PCNA/cyclin expression in transitional cell carcinomas of the human bladder: its correlation with Ki-67 and epidermal growth factor receptor immunostainings.
    Serio G
    Pathologica; 1994 Apr; 86(2):161-6. PubMed ID: 7936759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cell kinetics of oligodendroglioma and oligo-astrocytoma--Ki-67 PaP study].
    Shibata T; Burger PC; Kleihues P
    No To Shinkei; 1988 Aug; 40(8):779-85. PubMed ID: 3052541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ki-67 immunoreactivity in meningiomas--determination of the proliferative potential of meningiomas using the monoclonal antibody Ki-67.
    Madsen C; Schrøder HD
    Clin Neuropathol; 1997; 16(3):137-42. PubMed ID: 9197938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MIB-1 staining index and peritumoral brain edema of meningiomas.
    Ide M; Jimbo M; Yamamoto M; Umebara Y; Hagiwara S; Kubo O
    Cancer; 1996 Jul; 78(1):133-43. PubMed ID: 8646709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases.
    Roser F; Samii M; Ostertag H; Bellinzona M
    Acta Neurochir (Wien); 2004 Jan; 146(1):37-44; discussion 44. PubMed ID: 14740263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell proliferation correlates with prognosis in acinic cell carcinomas of salivary gland origin. Immunohistochemical study of 30 cases using the MIB 1 antibody in formalin-fixed paraffin sections.
    Skalova A; Leivo I; Von Boguslawsky K; Saksela E
    J Pathol; 1994 May; 173(1):13-21. PubMed ID: 7931834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferation markers Ki-67 and p105 in soft-tissue lesions. Correlation with DNA flow cytometric characteristics.
    Swanson SA; Brooks JJ
    Am J Pathol; 1990 Dec; 137(6):1491-500. PubMed ID: 1979714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunocytochemical evaluation of proliferative activity in human brain tumours.
    Girino M; Riccardi A; Danova M; Gaetani P; Butti G; Giordano M; Cuomo A
    Anal Cell Pathol; 1990 Sep; 2(5):269-75. PubMed ID: 2275874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrarapid Ki-67 immunostaining in frozen section interpretation of gliomas.
    Haapasalo J; Mennander A; Helen P; Haapasalo H; Isola J
    J Clin Pathol; 2005 Mar; 58(3):263-8. PubMed ID: 15735157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In situ determination of the Ki-67 growth fraction (Ki-67 GF) in human tumors (studies in breast cancer)].
    Lellé RJ
    Acta Histochem Suppl; 1990; 39():109-24. PubMed ID: 2080254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cellular kinetics of cerebral glioma: study of the proliferative activity using monoclonal antibody Ki 67. Apropos of 60 cases].
    Parent M; Blond S; Gosset P; Lejeune JP; Lesoin F; Dhellemmes P; Jomin M; Christiaens JL; Dupont A
    Arch Anat Cytol Pathol; 1990; 38(3):81-5. PubMed ID: 2363592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.